Dentsply Sirona Unit Wellspect HealthCare Announces That Its Surity Urinary Management Portfolio May Be Covered By Traditional Medicare For Eligible Beneficiaries When Medically Necessary
This milestone represents an important step in expanding access and reducing barriers to at-home management for people affected by severe urinary incontinence in the U.S. The Surity™ portfolio provides non-invasive
A Dentsply Sirona product for urinary care got Medicare approval. This means more patients can afford the treatment they need.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.